Our portfolio partners are essential components to our firm and we accomplish a lot together.
PORTFOLIO:
Centenary Group
Website: www.centenarygroup.co.ug
Sector: Banking & Financial Services
Summary
Centenary Group is currently the 2nd largest bank in Uganda, Africa. The bank opened its first branch in 1985. The bank is seeking to become the preferred bank in innovative business and financial inclusion solutions. The bank’s mission is to transform the lives of the people and promote environmental conservation, through innovative businesses. The company’s core values have a strong commitment to high standards of performance and to work with both our internal and external stakeholders, with a high level of commitment, consistency, and excellence.
Onfon Media
Website: www.onfonmedia.com
Sector: Mobile Telecommunications
Summary
Onfon Media was created to spearhead the supply affordable smartphones across Africa. The company is headquartered in Nairobi, Kenya and the main branch covers the East and Central African market. The company’s mission is to enhance technology penetration in the African market by providing millions of Africans with affordable access to smartphones. The company’s vision is to have a connected Africa with affordable modern smartphones.
DBA Shared Global Services Inc.
Website: www.dbaadvisory.com
Sector: Financial - Technology
Summary
DBA Global Shared Serivces Inc. is a premier Phillipines based company that offers professional outsourcing accountancy. The company works with accounting firms, private businesses, government entities, financial planning firms, and law firms administrators including multi-disciplinary organizations in other locations such as Singapore, the UK, and the USA. The company offers clients IT services, audit, administrative, legal, conveyance, tax, accounting, and financial planning change management services.
New Quantum
Website: www.newquantum.com
Sector: Financial -Technology
Summary
New Quantum is an Australian based “Financial Technology service company (FaaS) that service a business-to-business (B2B) platform, that powers innovation in financial technology, investing, and wealth management. The company provides a modern, mission critical suite of solutions to clients, enabling the company to revolutionize digital finance. The company’s platform combines risk analytics with portfolio management, trading, compliance, and operation tools on a single platform to power informed decision-making, risk management, client collaboration, and operational scale.
Levolta Pharmaceuticals
Website: www.levoltapharma.com
Sector: Healthcare - Bio-Technology/Pharmaceuticals
Summary
Levolta Pharmaceuticals incorporated in 2013, formed through a couple of mergers and created a portfolio of compounds. The company is in Phase III Clinical trials for its’ promising drug Volt01, that will target patients who have osteoarthritis. The company is a First-in-Class, disease-modifying single IV injection, for osteoarthritis. Levolta Pharmaceuticals mission is to market its’ promising drug which will relieve pain and increase mobility, with a single IV injection once a year. The promising drug efficacy is statistically significantly superior for decreasing of pain (note large reduction in Mean VAS Score at six months. The company’s product safety is superior and is measured by Post Dose Syndrome (PDS) and has no decrease in bone mineral density.
Company: African Integrated Development Enterprises (AIDE)
Website: www.aide.com
Sector: Healthcare - Integrated Community Hospitals
Summary
African Integrated Development Enterprises is an integrated healthcare system provider for primary, secondary, and tertiary healthcare services in strategic global geographical focus areas. The company develops and jointly operates high quality medical integrated healthcare systems, offering patient centric primary, specialty, and ancillary care. The company’s healthcare operations are led by a skilled team of international operators and practitioners. The company has engaged both foreign and domestic technical partners for operations, to implement their healthcare delivery systems. The company aims to become a global leader in healthcare delivery systems.
Company: Neurotez Inc.
Website: www.neurotez.com
Sector: Pharmaceutical Manufacturing
Summary
Neurotez Inc. is a vibrant biotechnology company targeting major Central Nervous System (CNS) disorders and Alzheimers disease which is an unmet market. The company’s primary drug is called Memtin (Leptin) and is a replacement therapy drug. The company offers its’ unparalleled talent and capabilities to transform Alzheimer’s disease by offering a very promising solution to a critical unmet need. The company have a patented hormone replacement therapy that is relatively de-risked multi-functional, preventative, and therapeutic approach for cognitive decline due to Alzheimer’s disease and optimally for early stage (prodromal AD) hyporleptinemic including other dementias.
Company: Anti-Cancer Inc.
Website: www.anticancer.com
Sector: Pharmaceutical Manufacturing
Summary
Anti-Cancer Inc. is a privately held company that develop, manufacture, and market therapeutic drugs to patients on chemotherapy. The company has a plethora of experience in the pharmaceutical space and will introduce to the market place new and improved anti-cancer products that will enhance and save lives. The company will mass produce new drugs approved by the Federal Drug Administration (FDA). The company has been issued and allowed (150) patents, (20) licenses, and has been published in (1000) scientific publications. The company is in the forefront of change concerning technology and breakthroughs in science.
Company: The BrainWare Learning Corporation
Website: www.brainware.com
Sector: Consumer Education (Cognitive Software)
Summary
The BrainWare Learning Corporation is a leading-edge brain fitness software company that operates at the crossroads of neuroscience and gaming. BrainWare Learning Corporation products develop and strengthen cognitive capacity for individuals 6 years and older. The products are self-paced with an emphasis on the individual learner.